2015
Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis
Al Nofal A, Altayar O, BenKhadra K, Qasim Agha O, Asi N, Nabhan M, Prokop L, Tebben P, Murad M. Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis. Osteoporosis International 2015, 26: 1875-1891. PMID: 26037791, DOI: 10.1007/s00198-015-3095-0.Peer-Reviewed Original ResearchMeSH KeywordsAlkaline PhosphataseBiomarkersBone Density Conservation AgentsBone RemodelingDiphosphonatesHumansOsteitis DeformansRadionuclide ImagingConceptsBone turnover markersBone turnover marker concentrationsTurnover markersDisease activityDisease of bonePaget's diseaseBone ALPBone scintigraphyMeta-analysisConcentrations of bone turnover markersIntroductionPaget’s disease of boneMeta-analysis searching MEDLINEUrine N-terminal telopeptideProcollagen type 1 amino-terminal propeptideSystematic reviewBone-specific alkaline phosphataseMarkers of disease activityCorrelation of disease activityPresence of liver diseaseDisease patientsCochrane Central Register of Controlled TrialsQuantitative bone scintigraphyCentral Register of Controlled TrialsC-terminal telopeptideN-terminal telopeptide
2006
Oncogenic Osteomalacia: Localization of Underlying Peripheral Mesenchymal Tumors with Use of Tc 99m Sestamibi Scintigraphy
Hodgson S, Clarke B, Tebben P, Mullan B, Cooney W, Shives T. Oncogenic Osteomalacia: Localization of Underlying Peripheral Mesenchymal Tumors with Use of Tc 99m Sestamibi Scintigraphy. Endocrine Practice 2006, 12: 35-42. PMID: 16524861, DOI: 10.4158/ep.12.1.35.Peer-Reviewed Original ResearchConceptsTc-99m sestamibi scanM sestamibi scanMesenchymal tumorsTc-99m sestamibi scintigraphyM sestamibi scintigraphyCost-effective initial strategyOncogenic osteomalaciaTherapeutic failureComplete resolutionCase reportD concentrationsNeoplasmsTumorTissue compartmentsOsteomalaciaAlternative localization technique